Insiders Vor Biopharma Inc.

Equities

VOR

US9290331084

Market Closed - Nasdaq Other stock markets 04:00:00 2024-06-11 pm EDT			5-day change	1st Jan Change
1.25 ^USD	-3.85%		-5.30%	-44.44%

Jun. 10	Vor Biopharma Inc. Announces Management Appointments, Effective June 21, 2024	CI
Jun. 10	Nathan Jorgensen Resigns as Chief Financial Officer of Vor Biopharma Inc., Effective June 21, 2024	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Vor Biopharma Inc. Announces Management Appointments, Effective June 21, 2024	Jun. 10	CI
Nathan Jorgensen Resigns as Chief Financial Officer of Vor Biopharma Inc., Effective June 21, 2024	Jun. 10	CI
Vor Biopharma Inc. Appoints Fouad Namouni as Class II Director	May. 02	CI
Vor Biopharma Inc. Announces Resignation of Kush Parmar, Member of the Board of Directors	23-04-14	CI
Vor Bio Appoints Eyal C. Attar, M.D. as Chief Medical Officer	22-10-12	CI
Vor Biopharma Chief Medical Officer Christopher Slapak to Retire	22-04-14	MT
Vor Biopharma Inc. Announces Retirement of Christopher Slapak as Chief Medical Officer	22-04-14	CI
Insider Sell: Vor Biopharma	21-11-19	MT
Vor Biopharma Announces the Appointment of Veit Schmelmer as Senior Vice President of Program and Alliance Management	21-10-12	CI
Vor Biopharma Announces Management Changes	21-06-11	CI
Vor Biopharma Promotes Tirtha Chakraborty to Chief Scientific Officer	20-11-19	CI
Vor Biopharma Appoints Matthew Patterson to Its Board of Directors	20-11-06	CI
Vor Biopharma, Inc. Appoints Matthew R Patterson to Its Board of Directors	20-10-20	CI
Vor Biopharma Appoints John King as Chief Commercial Officer	20-09-07	CI
Vor Biopharma, Appoints John King as Chief Commercial Officer	20-08-26	CI
Vor Biopharma Appoints David Lubner to its Board of Directors	20-07-30	CI
Vor Biopharma Appoints Daniella Beckman to Board of Directors	20-07-16	CI
Vor Biopharma Appoints Christopher Slapak as Chief Medical Officer	20-07-14	CI
Vor Biopharma, Inc. Announces Appointment of Nathan Jorgensen as Chief Financial Officer	20-05-26	CI
Vor Biopharma Appoints Dr. Robert Pietrusko as Chief Regulatory and Quality Officer	20-04-07	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders Vor Biopharma Inc.

Equities

VOR

US9290331084

Insiders

Filters